For a note on the conference at the Healthcare Economist blog by Jason Shafrin, here. For the conference website (including numerous downloadable papers and powerpoints), here.
I've also cut/pasted the conference agenda after the break.
For materials in one zip file (see down arrow to download) here.
NATIONAL BUREAU OF ECONOMIC RESEARCH, INC.
Pre-Conference on Economic Dimensions of Personalized and Precision Medicine
Supported by USC Schaeffer Center for Health Policy & Economics and Columbia University
Ernst Berndt, Dana Goldman, and John Rowe, Organizers
September 21-22, 2016
The Italian Academy for Advanced Studies in America
Library, Third Floor
1161 Amsterdam Avenue
New York, NY
Speakers should expect to present for 15-20 minutes to leave adequate time for discussion.
This time limit will be enforced by the organizers.
Wednesday, September 21:
Amitabh Chandra, Harvard University and NBER
Craig Garthwaite, Northwestern University and NBER
Ariel Dora Stern, Harvard University
Characterizing The Drug Development Pipeline for Precision Therapies
Manuel Hermosilla, Johns Hopkins University
Jorge Lemus, Northwestern University
Technological Hype and Innovation: Evidence from the Human Genome
Philippe Gorry, University of Bordeaux
Empirical Economic Analysis of Orphan Drug Innovation
Kristopher Hult, University of ChicagoMeasuring the Potential Health Impact of Personalized Medicine: Evidence from MS Treatments
Mark Pauly, University of Pennsylvania and NBERCost Sharing in Insurance Coverage for Precision Medicine: Preliminary Notes
Tomas Philipson, University of Chicago and NBER
The New Information Economics of Personalized Medicine: Current Findings and Future Research
Serafina, 2178 Broadway (at 77th) New York, NY
in the NYLO Hotel
Thursday, September 22:
Frank Lichtenberg, Columbia University and NBER
Rebecca Pulk, Geisinger Health System
Marc Williams, Geisinger Health System
Eric Wright, Geisinger Health System
The Social Cost of Suboptimal Medication Use and the Value of Pharmacogenomic Information: Evidence fromGeisinger Health System
John Graves, Vanderbilt University
Josh Peterson, Vanderbilt University
Rational Integration of Genomic Health Care Technology: Evidence from PREDICT
Guy David, University of Pennsylvania and NBER
Jason Hockenberry, Emory University and NBER
David Howard, Emory UniversityPersonalized Medicine in Action: The Case of Intensity Modulated Radiation Therapy
Karen Eggleston, Stanford University and NBER
Rachel Jui-f. Lu, Chang Gung University, Taiwan
Economic Dimensions of Personalized and Precision Medicine in Taiwan and Korea: Evidence from Breast Cancer Treatment
Darius Lakdawalla, University of Southern California and NBER
Jason Shafrin, Precision Health EconomicsPredicting Real-World Effectiveness Using Overall Survival and Progression-Free Survival from Clinical Trials: Empirical Evidence for the ASCO Value Framework